A Study to Estimate the Effect of AZD5718 on the Pharmacokinetics (What Does the Body Does to the Drug) of Rosuvastatin to Measure the Relative Bioavailability (the Extent to Which a Drug or Other Substance Becomes Available to the Body) of AZD5718 Oral Suspension vs AZD5718 Immediate Release Tablet

NCT02963116 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

High Risk Coronary Artery Disease

Interventions

DRUG: AZD5718 IR tablet
DRUG: AZD5718 oral suspension
DRUG: Rosuvastatin tablet

Sponsor

AstraZeneca